# Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers

> **NCT01504984** · PHASE1 · COMPLETED · sponsor: **Samyang Biopharmaceuticals Corporation** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SYO-1126
- **DRUG:** Glivec film coated tab 4T(400mg)

## Key facts

- **NCT ID:** NCT01504984
- **Lead sponsor:** Samyang Biopharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504984, "Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01504984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*